Purdue Pharma in discussion on US$10bil-$12bil offer to settle opioid lawsuits


Bottles of prescription painkiller OxyContin pills, made by Purdue Pharma sit on a counter at a local pharmacy in Provo, Utah, US. - File pic Reuters

NEW YORK: OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for US$10 billion to $12 billion, two people familiar with the matter said on Tuesday.

Purdue is among several drugmakers and distributors that have been sued for fueling an opioid addiction crisis in the United States, which claimed 400,000 lives from 1999 to 2017, according to the U.S. Centers for Disease Control and Prevention.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

OxyContin , Purdue Pharman , lawsuit , US$10 billion , settle ,

   

Next In Business News

Feytech signs underwriting agreement for listing on Main Market
EPF Account 3 draws concerns over dividends
Developers gearing up for higher sales
Kimlun wins RM150mil deal from Astaka
Systech gets shareholders’ nod for capital exercise
Huawei starts new smartphone Pura 70 sale amid scrutiny on chips
Smart Asia en route for listing on ACE Market
IGB-REIT likely to maintain organic growth
State-owned enterprises achieve milestone in key HSR construction
Trading suspension for Awanbiru

Others Also Read